Barclays PLC grew its position in Transcat, Inc. (NASDAQ:TRNS - Free Report) by 393.0% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 15,130 shares of the scientific and technical instruments company's stock after acquiring an additional 12,061 shares during the quarter. Barclays PLC owned 0.16% of Transcat worth $1,826,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other hedge funds have also modified their holdings of TRNS. DekaBank Deutsche Girozentrale bought a new position in shares of Transcat in the 2nd quarter valued at about $40,000. nVerses Capital LLC bought a new stake in shares of Transcat in the 3rd quarter valued at approximately $60,000. Quest Partners LLC purchased a new position in shares of Transcat in the 2nd quarter worth approximately $109,000. US Bancorp DE boosted its holdings in shares of Transcat by 15.6% in the 3rd quarter. US Bancorp DE now owns 1,547 shares of the scientific and technical instruments company's stock worth $187,000 after purchasing an additional 209 shares during the period. Finally, Captrust Financial Advisors bought a new position in shares of Transcat during the 3rd quarter valued at approximately $201,000. 98.34% of the stock is owned by hedge funds and other institutional investors.
Transcat Price Performance
TRNS stock traded down $1.92 during mid-day trading on Friday, reaching $106.01. The company had a trading volume of 37,952 shares, compared to its average volume of 55,036. The firm has a 50 day moving average of $107.62 and a 200 day moving average of $117.98. Transcat, Inc. has a 12 month low of $94.29 and a 12 month high of $147.12. The company has a market capitalization of $975.19 million, a PE ratio of 53.54 and a beta of 0.70.
Transcat (NASDAQ:TRNS - Get Free Report) last announced its quarterly earnings data on Monday, October 28th. The scientific and technical instruments company reported $0.35 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.47 by ($0.12). The firm had revenue of $67.83 million during the quarter, compared to the consensus estimate of $70.30 million. Transcat had a return on equity of 7.36% and a net margin of 6.63%. The firm's revenue for the quarter was up 8.0% compared to the same quarter last year. During the same period last year, the company earned $0.41 EPS. Analysts anticipate that Transcat, Inc. will post 1.76 EPS for the current year.
Wall Street Analyst Weigh In
Several research analysts have commented on the stock. Northland Securities dropped their price objective on shares of Transcat from $130.00 to $110.00 and set a "market perform" rating for the company in a research note on Wednesday, October 30th. Craig Hallum upped their price target on shares of Transcat from $113.00 to $125.00 and gave the company a "buy" rating in a report on Thursday, December 12th. StockNews.com downgraded shares of Transcat from a "hold" rating to a "sell" rating in a research note on Tuesday, October 29th. HC Wainwright reaffirmed a "buy" rating and set a $156.00 target price on shares of Transcat in a research note on Tuesday, October 29th. Finally, Oppenheimer reissued an "outperform" rating and set a $130.00 price target (down from $155.00) on shares of Transcat in a research note on Wednesday, October 30th. One research analyst has rated the stock with a sell rating, two have assigned a hold rating and three have issued a buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of "Hold" and an average price target of $130.25.
Check Out Our Latest Stock Analysis on Transcat
Transcat Profile
(
Free Report)
Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.
Featured Stories
Before you consider Transcat, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Transcat wasn't on the list.
While Transcat currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.